ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE says no to expanding use of AZ’ Lynparza
pharmatimes
November 12, 2018The National Institute for Health and Care Excellence has ruled against expanding use of AstraZeneca’s Lynparza to a wider patient population with ovarian cancer.
Pharma Sources Insight July 2025
